Haleon PLC Sponsored ADR
HLN Healthcare Drug Manufacturers Specialty & Generic
Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.
Follow HLN
Alert me
Haleon PLC Sponsored ADR (HLN) Book value per share
Haleon PLC Sponsored ADR's book value per share at the end of fiscal 2025 was 4.8×, up 6.60% from 4.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 0.0×. Over the past ten years it has ranged from 4.4× (fiscal 2022) to 7.8× (fiscal 2019); the current reading is higher than 57% of that period. Haleon PLC Sponsored ADR ranks 58th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 4.8× | 6.60% |
| FY2024 | 4.5× | 0.73% |
| FY2023 | 4.5× | 2.25% |
| FY2022 | 4.4× | (42.81%) |
| FY2021 | 7.7× | (0.43%) |
| FY2020 | 7.7× | (0.50%) |
| FY2019 | 7.8× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| Mar 2024 | 0.0× | — |
| 4 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UTHR United Therapeutics Corporation compare | 147× |
| NBIX Neurocrine Biosciences, Inc. compare | 38.2× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| ZTS Zoetis Inc. compare | 7.5× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 6.8× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| TAK Takeda Pharmaceutical Co. compare | 0.0× |
| HLN Haleon PLC Sponsored ADR | 0.0× |
| VTRS Viatris Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HLN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Altman Z-score
- Beneish M-score
- The full statement